424 related articles for article (PubMed ID: 25597275)
1. Therapeutic strategy for pandrug-resistant Klebsiella pneumoniae severe infections: short-course treatment with colistin increases the in vivo and in vitro activity of double carbapenem regimen.
Oliva A; Mascellino MT; Cipolla A; D'Abramo A; De Rosa A; Savinelli S; Ciardi MR; Mastroianni CM; Vullo V
Int J Infect Dis; 2015 Apr; 33():132-4. PubMed ID: 25597275
[TBL] [Abstract][Full Text] [Related]
2. Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014.
Monaco M; Giani T; Raffone M; Arena F; Garcia-Fernandez A; Pollini S; ; Grundmann H; Pantosti A; Rossolini GM
Euro Surveill; 2014 Oct; 19(42):. PubMed ID: 25358041
[TBL] [Abstract][Full Text] [Related]
3. Colistin resistance emerges in pandrug-resistant Klebsiella pneumoniae epidemic clones in Rio de Janeiro, Brazil.
Longo LGA; de Sousa VS; Kraychete GB; Justo-da-Silva LH; Rocha JA; Superti SV; Bonelli RR; Martins IS; Moreira BM
Int J Antimicrob Agents; 2019 Nov; 54(5):579-586. PubMed ID: 31479740
[TBL] [Abstract][Full Text] [Related]
4. Hospital Outbreak of a Colistin-Resistant, NDM-1- and OXA-48-Producing Klebsiella pneumoniae: High Mortality from Pandrug Resistance.
Guducuoglu H; Gursoy NC; Yakupogullari Y; Parlak M; Karasin G; Sunnetcioglu M; Otlu B
Microb Drug Resist; 2018 Sep; 24(7):966-972. PubMed ID: 29265963
[TBL] [Abstract][Full Text] [Related]
5. Carbapenem-resistant Klebsiella pneumoniae endocarditis in a young adult. Successful treatment with gentamicin and colistin.
Benenson S; Navon-Venezia S; Carmeli Y; Adler A; Strahilevitz J; Moses AE; Block C
Int J Infect Dis; 2009 Sep; 13(5):e295-8. PubMed ID: 19329345
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value.
Oliva A; Scorzolini L; Cipolla A; Mascellino MT; Cancelli F; Castaldi D; D'Abramo A; D'Agostino C; Russo G; Ciardi MR; Mastroianni CM; Vullo V
J Antimicrob Chemother; 2017 Jul; 72(7):1981-1984. PubMed ID: 28369424
[TBL] [Abstract][Full Text] [Related]
7. Genomic analysis of a pan-resistant Klebsiella pneumoniae sequence type 11 identified in Japan in 2016.
Nishida S; Ono Y
Int J Antimicrob Agents; 2020 Apr; 55(4):105854. PubMed ID: 31770626
[TBL] [Abstract][Full Text] [Related]
8. Effect of Resistance Mechanisms on the Inoculum Effect of Carbapenem in Klebsiella pneumoniae Isolates with Borderline Carbapenem Resistance.
Adler A; Ben-Dalak M; Chmelnitsky I; Carmeli Y
Antimicrob Agents Chemother; 2015 Aug; 59(8):5014-7. PubMed ID: 25987630
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of mgrB gene regulator and resistance to colistin is becoming endemic in carbapenem-resistant Klebsiella pneumoniae in Greece: A nationwide study from 2014 to 2017.
Hamel M; Chatzipanagiotou S; Hadjadj L; Petinaki E; Papagianni S; Charalampaki N; Tsiplakou S; Papaioannou V; Skarmoutsou N; Spiliopoulou I; Christofidou M; Papamichalopoulos N; Skalidis T; Legakis N; Fountoulis K; Perivolioti E; Kraniotaki H; Bournia M; Ioannidis A; Baron Sophie A; Rolain JM
Int J Antimicrob Agents; 2020 Apr; 55(4):105930. PubMed ID: 32130981
[TBL] [Abstract][Full Text] [Related]
10. Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance.
Ku YH; Chen CC; Lee MF; Chuang YC; Tang HJ; Yu WL
J Microbiol Immunol Infect; 2017 Dec; 50(6):931-939. PubMed ID: 28716360
[TBL] [Abstract][Full Text] [Related]
11. Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems.
Machuca I; Gutiérrez-Gutiérrez B; Gracia-Ahufinger I; Rivera Espinar F; Cano Á; Guzmán-Puche J; Pérez-Nadales E; Natera C; Rodríguez M; León R; Castón JJ; Rodríguez-López F; Rodríguez-Baño J; Torre-Cisneros J
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559247
[TBL] [Abstract][Full Text] [Related]
12. Synergistic activity of colistin plus rifampin against colistin-resistant KPC-producing Klebsiella pneumoniae.
Tascini C; Tagliaferri E; Giani T; Leonildi A; Flammini S; Casini B; Lewis R; Ferranti S; Rossolini GM; Menichetti F
Antimicrob Agents Chemother; 2013 Aug; 57(8):3990-3. PubMed ID: 23752510
[TBL] [Abstract][Full Text] [Related]
13. First Detection of Colistin-Resistant
Nawfal Dagher T; Azar E; Al-Bayssari C; Chamieh AS; Rolain JM
Microb Drug Resist; 2019; 25(6):925-930. PubMed ID: 30883263
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of antimicrobial combinations against colistin-resistant carbapenemase (KPC)-producing Klebsiella pneumoniae.
Maraki S; Papadakis IS
J Chemother; 2015; 27(6):348-52. PubMed ID: 25248023
[No Abstract] [Full Text] [Related]
15. Characterization of porin expression in Klebsiella pneumoniae Carbapenemase (KPC)-producing K. pneumoniae identifies isolates most susceptible to the combination of colistin and carbapenems.
Hong JH; Clancy CJ; Cheng S; Shields RK; Chen L; Doi Y; Zhao Y; Perlin DS; Kreiswirth BN; Nguyen MH
Antimicrob Agents Chemother; 2013 May; 57(5):2147-53. PubMed ID: 23459476
[TBL] [Abstract][Full Text] [Related]
16. Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality.
Rojas LJ; Salim M; Cober E; Richter SS; Perez F; Salata RA; Kalayjian RC; Watkins RR; Marshall S; Rudin SD; Domitrovic TN; Hujer AM; Hujer KM; Doi Y; Kaye KS; Evans S; Fowler VG; Bonomo RA; van Duin D;
Clin Infect Dis; 2017 Mar; 64(6):711-718. PubMed ID: 27940944
[TBL] [Abstract][Full Text] [Related]
17. Doripenem MICs and ompK36 porin genotypes of sequence type 258, KPC-producing Klebsiella pneumoniae may predict responses to carbapenem-colistin combination therapy among patients with bacteremia.
Shields RK; Nguyen MH; Potoski BA; Press EG; Chen L; Kreiswirth BN; Clarke LG; Eschenauer GA; Clancy CJ
Antimicrob Agents Chemother; 2015 Mar; 59(3):1797-801. PubMed ID: 25534733
[TBL] [Abstract][Full Text] [Related]
18. Successful Treatment of Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae Bacteremia.
Camargo JF; Simkins J; Beduschi T; Tekin A; Aragon L; Pérez-Cardona A; Prado CE; Morris MI; Abbo LM; Cantón R
Antimicrob Agents Chemother; 2015 Oct; 59(10):5903-8. PubMed ID: 26386029
[TBL] [Abstract][Full Text] [Related]
19. Microbiological and molecular characterization of extreme drug-resistant carbapenemase-producing Klebsiella pneumoniae isolates.
Santino I; Bono S; Nuccitelli A; Martinelli D; Petrucci C; Alari A
Int J Immunopathol Pharmacol; 2013; 26(3):785-90. PubMed ID: 24067478
[TBL] [Abstract][Full Text] [Related]
20. The combination of doripenem and colistin is bactericidal and synergistic against colistin-resistant, carbapenemase-producing Klebsiella pneumoniae.
Jernigan MG; Press EG; Nguyen MH; Clancy CJ; Shields RK
Antimicrob Agents Chemother; 2012 Jun; 56(6):3395-8. PubMed ID: 22430958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
